The current price range in HICs for nirsevimab in the public sector varies between US$ 231 and US$ 730 per dose and maternal RSVPreF vaccine ranges between US$ 205 and US$ 234 per dose. In the US the price for the two monoclonal antibodies is the same: US$556 per dose. Go to footnote 1, Go to footnote 2
Pfizer has made a public commitment to develop a multidose vial that will be available in the coming years at a supply and price for the Gavi-eligible market, which is expected to be low and similarly to other vaccines funded by Gavi. Go to footnote 3
PAHO revolving fund has negotiated a price for maternal RSVpreF vaccine for Latin American countries of US$ 49 per dose.
To date, no price commitment for LMICs for monoclonal antibodies has been made. Go to footnote 4
- Go back to footnote reference 1
World Health Organization (2024). WHO global market study – RSV immunization products. Geneva: World Health Organization (https://cdn.who.int/media/docs/default-source/immunization/mi4a/who_global_market_study_on_rsv_immunization_products_sep-2024.pdf, accessed 20 June 2025).
- Go back to footnote reference 2
Pan American Health Organization (2025). PAHO vaccine prices for 2025. Washington (DC): PAHO (https://www.paho.org/sites/default/files/2025-02/prices-vac-2025-eng-27-feb-25.pdf, accessed 20 June 2025).
- Go back to footnote reference 3
World Health Organization (2024). WHO global market study – RSV immunization products. Geneva: World Health Organization (https://cdn.who.int/media/docs/default-source/immunization/mi4a/who_global_market_study_on_rsv_immunization_products_sep-2024.pdf, accessed 20 June 2025).
- Go back to footnote reference 4
United States Centers for Disease Control and Prevention (2025). CDC vaccine price list for childhood vaccines. Atlanta (GA): US CDC (https://www.cdc.gov/vaccines-for-children/php/awardees/current-cdc-vaccine-price-list.html, accessed 20 June 2025).
